Abbott Labs To Become Leader In Point-Of-Care Diagnostic Testing With $5.8 Billion Investment To Buy Medical Test Maker Alere Abbott Laboratories is buying Alere for $5.8 billion in its bid to lead the point-of-care diagnostic testing market. It is currently trailing behind Roche in the global diagnostics business but expects to soar to over $7 billion after the deal. by Katrina Pascual